Primary stenting of the superficial femoral and popliteal artery

Slides:

Advertisements

Similar presentations

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Stenting of femoropopliteal lesions using interwoven nitinol stents

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score Daniel M. Ihnat,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation Rahim Aimaq, MD, Steven.

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Magdiel Trinidad-Hernandez, MD, Joseph J

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Evolving treatment of popliteal artery aneurysms

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Miguel Montero-Baker, MD, Gregory J

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Current guidelines produce competent endovascular surgeons

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access Evan R. Brownie,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Virendra I. Patel, MD, Mark F. Conrad, MD, Christopher J

Vincent L. Rowe, MD, William Lee, MD, Fred A

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Amy N. Roach, BS, Sebastian Larion, MS, Sadaf S. Ahanchi, MD, Chad P

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Sukgu M. Han, MD, Fred A. Weaver, MD, MMM, Anthony J

Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD,

Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts Ahsan T. Ali, MD, J. Gregory Modrall,

Infrainguinal cutting balloon angioplasty in de novo arterial lesions

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Axillary loop grafts for hemodialysis access: Midterm results from a single-center study Elixène Jean-Baptiste, MD, Réda Hassen-Khodja, MD, Pierre Haudebourg,

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Karen Woo, MD, Jens Eldrup-Jorgensen, MD, John W. Hallett, MD, Mark G

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Ryan M. Svoboda, Kristina A. Giles, Samantha A. Connell, Daniel B

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Ilia Gur, MD, William Lee, MD, Gabriel Akopian, MD, Vincent L

Hypogastric and subclavian artery patency affects onset and recovery of spinal cord ischemia associated with aortic endografting Matthew J. Eagleton,

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

The influence of gender on patency rates after iliac artery stenting

David H. Stone, MD, David C. Brewster, MD, Christopher J

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Percutaneous intervention for infrageniculate arterial disease in women may be associated with better outcomes when compared to men Andrew Tye, BA, Daniel.

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries Laura A. Karch, MD, Mark A. Mattos, MD,

Complications of iliac artery stent deployment

Charles S. Joels, MD, John W. York, MD, Corey A. Kalbaugh, MS, David L

Endoscopic vein harvest for infrainguinal arterial bypass

Endovascular repair of an acute blunt popliteal artery injury

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery Luis R. León, MD, RVT, Robert.

Early results of stent-grafting to treat diffuse aortoiliac occlusive disease Eva M Rzucidlo, MD, Richard J Powell, MD, Robert M Zwolak, MD, PhD, Mark.

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England Ryan M. Svoboda, Karina A.

Popliteal artery aneurysms: a comparison of outcomes in elective versus emergent repair Bernadette Aulivola, MD, Allen D Hamdan, MD, Chantel N Hile,

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Determinants of successful peroneal artery bypass

Endovascular interventions for TASC II D femoropopliteal lesions

Endovascular brachytherapy for renal artery in-stent restenosis

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Thigh claudication due to profunda femoris artery occlusion

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

John F. Eidt, MD, Elliot Chaikof, MD, PhD, Anton N. Sidawy, MD, MPH

Presentation transcript:

Primary stenting of the superficial femoral and popliteal artery David D. Dearing, MD, Kaushal R. Patel, MD, John M. Compoginis, MD, Mary A. Kamel, BA, Fred A. Weaver, MD, Steven G. Katz, MD Journal of Vascular Surgery Volume 50, Issue 3, Pages 542-547 (September 2009) DOI: 10.1016/j.jvs.2009.04.019 Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 1 Survival curve showing primary patency for all stented arterial segments. Standard error did not exceed 10% until 40 months of follow-up. Hatch marks represent events in which a stented segment lost primary patency. Journal of Vascular Surgery 2009 50, 542-547DOI: (10.1016/j.jvs.2009.04.019) Copyright © 2009 Society for Vascular Surgery Terms and Conditions

Fig 2 Survival curve showing primary patency for TASC A and B versus TASC C and D treated arterial segments. Standard error did not exceed 10% until 40 months of follow-up. Hatch marks represent events in which a stented segment lost primary patency. Log rank test: P < .001. TASC A/B, top line. TASC C/D, bottom line. Journal of Vascular Surgery 2009 50, 542-547DOI: (10.1016/j.jvs.2009.04.019) Copyright © 2009 Society for Vascular Surgery Terms and Conditions